In advanced clinical practice, up to 4/5th of the hospitalized patients require intravenous therapy at some point during their hospital stay. This intravenous route can involve administering ...

SwabFlush combines SwabCap and the ZR Catheter Flush Syringe into one device, to make it easier for nurses to flush, disinfect and protect the IV connector all at the same time. (Photo: Business Wire) ...

Stage-Specific Outcomes of Patients With Uterine Leiomyosarcoma: A Comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems During ...

DefenCath is intended for instillation into central venous catheters only. DefenCath ® (taurolidine and heparin) catheter lock solution is now available for inpatient use to reduce the incidence of ...

NATIONAL HARBOR, Md.--(BUSINESS WIRE)-- New research reports that the SwabCap® disinfection cap for luer access valves helped hospitals meet several challenges with IV valve disinfection and Joint ...

The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...

Heparin is routinely used to keep central venous catheters patent but is it the most effective flush solution? A systematic review was undertaken to find out AbstractAnderson BJ et al (2010) What is ...

The practice of flushing drainage catheters is important to maintain their effectiveness. Recording when drains are flushed helps the IR (interventional radiology) staff in evaluating the ...

NORTHFIELD, Ill.--(BUSINESS WIRE)--According to the CDC, considerable progress is being made in preventing central line associated blood stream infections, but further improvement is still needed. An ...

Retrospective studies suggest that it may be safe to extend the maintenance flushing interval of implanted ports from once every month, as recommended by the manufacturer, to once every 3 months, but ...

The FDA approved a taurolidine and heparin (DefenCath) catheter lock solution for reducing the risk of bloodstream infections in patients on dialysis. Approved under a special limited agency pathway, ...

NEPTUNE, N.J.--(BUSINESS WIRE)--Excelsior Medical Corporation announced today that it has received FDA 510(k) clearance for SwabFlush™, its latest product for the vascular access and infection control ...